-
February 01, 2013
Alkermes plc (ALKS) reported earnings of 14 cents per share in the third quarter of fiscal 2013 (ended December 31, ...
-
January 30, 2013
Vertex Pharmaceuticals Inc. (VRTX) posted a loss of 9 cents per share (including stock-based compensation expense) ...
-
January 25, 2013
Cadence Pharmaceuticals Inc. (CADX) recently announced that it expects preliminary net revenue of Ofirmev ...
-
January 25, 2013
Seattle Genetics Inc. (SGEN) and Takeda Pharmaceutical Company Limited (TKPYY) recently announced the commencement ...
-
January 25, 2013
Gilead Sciences Inc. (GILD) recently initiated the first of two phase III studies on tenofovir alafenamide (TAF). ...
-
January 24, 2013
Celgene Corporation's (CELG) fourth quarter 2012 earnings (excluding special items but including stock-based ...
-
January 18, 2013
Exelixis, Inc. (EXEL) recently announced that it has received a notice from its partner, Roche Holding (RHHBY), ...
-
January 18, 2013
InterMune Inc. (ITMN) recently priced its concurrent underwritten public offerings of convertible senior notes and ...
-
January 17, 2013
Amarin Corporation plc (AMRN), recently announced that the notice of patent allowance for US application serial ...
-
January 16, 2013
InterMune Inc. (ITMN) recently announced its intention to raise funds through concurrent underwritten public ...
-
January 16, 2013
Alnylam Pharmaceuticals Inc. (ALNY) provided pricing and other details regarding its recently announced public ...
-
January 16, 2013
Ironwood Pharmaceuticals, Inc.'s (IRWD) fourth-quarter 2012 loss of 41 cents per share compared unfavorably with the ...
-
January 15, 2013
Alnylam Pharmaceuticals Inc. (ALNY) recently began an underwritten public offering of shares of its common stock. ...
-
January 15, 2013
Shares of Celgene Corporation (CELG) hit a 52-week high of $97.71 almost at the end of the trading session on Jan ...
-
January 14, 2013
Jazz Pharmaceuticals plc (JAZZ) recently discussed its product portfolio and pipeline. Key products in the company's ...
-
January 14, 2013
Gilead Sciences (GILD) recently provided an update regarding its chronic hepatitis C virus (HCV) pipeline. We ...
-
January 08, 2013
Aegerion Pharmaceuticals Inc. (AEGR) recently announced its 2013 guidance as the company prepares for the launch of ...
-
January 08, 2013
Alnylam Pharmaceuticals Inc (ALNY) recently announced its goal for the next two years (2013 and 2014) regarding its ...
-
January 08, 2013
Celgene Corporation (CELG) recently provided an encouraging guidance for 2013. The biopharmaceutical company expects ...
-
January 07, 2013
Biotechnology company, BioMimetic Therapeutics, Inc. (BMTI) recently announced that it has started enrolling ...
